Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
23-Oct-2025 | 472.1 | 473.45 | 461 | 463.05 | 3,244 | 3,80,64,543.9 | 51,446 |
24-Oct-2025 | 461.05 | 466 | 456.05 | 460.55 | 5,317 | 3,55,49,540.95 | 36,356 |
27-Oct-2025 | 460 | 471.05 | 457.5 | 465.9 | 2,388 | 3,49,39,848 | 46,626 |
28-Oct-2025 | 465 | 466.85 | 453.35 | 457.2 | 3,825 | 4,61,88,054.25 | 59,362 |
29-Oct-2025 | 457.2 | 471.5 | 452.3 | 467 | 3,164 | 4,65,56,950.95 | 33,210 |
30-Oct-2025 | 471 | 471 | 462.5 | 466.9 | 2,438 | 3,42,44,386.65 | 41,596 |
31-Oct-2025 | 468.9 | 468.9 | 459 | 460.75 | 2,924 | 2,46,30,213.2 | 32,163 |
03-Nov-2025 | 463.95 | 473.4 | 461 | 467.65 | 4,128 | 3,27,81,223.55 | 38,669 |
04-Nov-2025 | 474.9 | 481.7 | 463.7 | 471.1 | 8,954 | 9,75,66,008.15 | 87,037 |
06-Nov-2025 | 475 | 475 | 458 | 460.35 | 3,407 | 4,41,72,034.7 | 56,499 |
07-Nov-2025 | 458.95 | 462 | 449.5 | 453.35 | 9,789 | 20,50,13,724.15 | 2,81,115 |
10-Nov-2025 | 452.1 | 456.75 | 428 | 438.8 | 7,203 | 11,49,91,693.9 | 1,62,957 |
11-Nov-2025 | 439.2 | 441.45 | 429.5 | 438.6 | 7,702 | 6,14,09,506.15 | 60,821 |
12-Nov-2025 | 440 | 458.1 | 434.7 | 453.15 | 10,593 | 12,89,86,586.2 | 1,28,383 |
13-Nov-2025 | 451.5 | 454.9 | 435.1 | 437.4 | 7,717 | 7,89,05,490.75 | 85,956 |
14-Nov-2025 | 430 | 432 | 415.05 | 424.3 | 21,550 | 33,92,56,878.75 | 4,54,902 |
17-Nov-2025 | 425.85 | 445.05 | 424.3 | 440.5 | 8,577 | 11,18,19,117.1 | 80,099 |
18-Nov-2025 | 436 | 439.8 | 428.7 | 430.3 | 6,146 | 8,98,06,078.15 | 1,00,816 |
19-Nov-2025 | 430.15 | 431.8 | 419.1 | 424.9 | 7,603 | 10,33,12,852.1 | 1,65,955 |
20-Nov-2025 | 427.55 | 429.2 | 420.5 | 421.55 | 4,476 | 3,42,90,213.7 | 50,613 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
